Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Accumulated Expenses (2021 - 2024)

Intelligent Bio Solutions has reported Accumulated Expenses over the past 4 years, most recently at $660010.0 for Q1 2024.

  • Quarterly results put Accumulated Expenses at $660010.0 for Q1 2024, up 71.11% from a year ago — trailing twelve months through Mar 2024 was $660010.0 (up 71.11% YoY), and the annual figure for FY2023 was $358942.0, down 60.52%.
  • Accumulated Expenses for Q1 2024 was $660010.0 at Intelligent Bio Solutions, up from $366893.0 in the prior quarter.
  • Over the last five years, Accumulated Expenses for INBS hit a ceiling of $909187.0 in Q2 2022 and a floor of $102475.0 in Q2 2021.
  • Median Accumulated Expenses over the past 4 years was $334205.5 (2022), compared with a mean of $352163.7.
  • Biggest five-year swings in Accumulated Expenses: soared 787.23% in 2022 and later tumbled 60.52% in 2023.
  • Intelligent Bio Solutions' Accumulated Expenses stood at $129212.0 in 2021, then soared by 139.5% to $309469.0 in 2022, then rose by 18.56% to $366893.0 in 2023, then soared by 79.89% to $660010.0 in 2024.
  • The last three reported values for Accumulated Expenses were $660010.0 (Q1 2024), $366893.0 (Q4 2023), and $406964.0 (Q3 2023) per Business Quant data.